Related references
Note: Only part of the references are listed.Orexin A/Hypocretin Modulates Leptin Receptor-Mediated Signaling by Allosteric Modulations Mediated by the Ghrelin GHS-R1A Receptor in Hypothalamic Neurons
Mireia Medrano et al.
MOLECULAR NEUROBIOLOGY (2018)
Cross-communication between Gi and Gs in a G-protein-coupled receptor heterotetramer guided by a receptor C-terminal domain
Gemma Navarro et al.
BMC BIOLOGY (2018)
Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia
Gemma Navarro et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Adenosine A2A receptor ligand recognition and signaling is blocked by A2B receptors
Sonja Hinz et al.
Oncotarget (2018)
Cannabinoid CB2 receptors are involved in the protection of RAW264.7 macrophages against the oxidative stress: an in vitro study
Sabrina Giacoppo et al.
EUROPEAN JOURNAL OF HISTOCHEMISTRY (2017)
Cannabis: A Treasure Trove or Pandora's Box?
Katalin Solymosi et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2017)
Zombie Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York
Axel J. Adams et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health
Aviv M. Weinstein et al.
FRONTIERS IN PSYCHIATRY (2017)
Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity
Xavier Nadal et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
An Introduction to the Endogenous Cannabinoid System
Hui-Chen Lu et al.
BIOLOGICAL PSYCHIATRY (2016)
Quaternary structure of a G-protein-coupled receptor heterotetramer in complex with Gi and Gs
Gemma Navarro et al.
BMC BIOLOGY (2016)
Two Affinity Sites of the Cannabinoid Subtype 2 Receptor Identified by a Novel Homogeneous Binding Assay
Eva Martinez-Pinilla et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Identification of amino acids that are selectively involved in Gi/o activation by rat melanin-concentrating hormone receptor 1
Akie Hamamoto et al.
CELLULAR SIGNALLING (2015)
Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism
Salvador Sierra et al.
BRAIN STRUCTURE & FUNCTION (2015)
Differences in receptor binding affinity of several phytocannabinoids do not explain their effects on neural cell cultures
Sarah Rosenthaler et al.
NEUROTOXICOLOGY AND TERATOLOGY (2014)
Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
Francesca Borrelli et al.
BIOCHEMICAL PHARMACOLOGY (2013)
AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor
Daniele Bolognini et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain
Lucia Callen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis
Aitor G. Granja et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
Luciano De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Bioactive Prenylogous Cannabinoid from Fiber Hemp (Cannabis sativa)
Federica Pollastro et al.
JOURNAL OF NATURAL PRODUCTS (2011)
Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis
Jose L. Lanciego et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors
Stefania Merighi et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Evidence that the plant cannabinoid cannabigerol is a highly potent alpha(2)-adrenoceptor agonist and moderately potent 5HT(1A) receptor antagonist
M. G. Cascio et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Interactions between Intracellular Domains as Key Determinants of the Quaternary Structure and Function of Receptor Heteromers
Gemma Navarro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The C-terminal Tail of CRTH2 Is a Key Molecular Determinant That Constrains Gαi and Downstream Signaling Cascade Activation
Ralf Schroeder et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
An optical dynamic mass redistribution assay reveals biased signaling of dualsteric GPCR activators
Anna Kebig et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2009)
Pharmacological Characterization of Receptor Redistribution and β-Arrestin Recruitment Assays for the Cannabinoid Receptor 1
Miranda M. C. van der Lee et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
Evaluating Cellular Impedance Assays for Detection of GPCR Pleiotropic Signaling and Functional Selectivity
Matthew F. Peters et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
Characterizing Cannabinoid CB2 Receptor Ligands Using DiscoveRx PathHunter (TM) beta-Arrestin Assay
Debra Mcguinness et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Unique agonist-bound cannabinoid CB1 receptor conformations indicate agonist specificity in signaling
Teodora Georgieva et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8
Luciano De Petrocellis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences
J. M. McPartland et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
WIN55212-2 docking to the CB1 cannabinoid receptor and multiple pathways for conformational induction
JY Shim et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE)
MA Diana et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Homology model of the CB1 cannabinoid receptor: Sites critical for nonclassical cannabinoid agonist interaction
JY Shim et al.
BIOPOLYMERS (2003)
The power issue:: determination of KB or Ki from IC50 -: A closer look at the Cheng-Prusoff equation, the Schild plot and related power equations
HC Cheng
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2001)
Share Paper
